Prognostic Value of Prelymphodepletion Absolute Lymphocyte Counts in Relapsed/Refractory DLBCL Patients Treated With CAR-T Cells
Here, study authors investigated the impact of pre-lymphodepletion absolute lymphocyte count on CAR-T cell therapy outcomes. Results demonstrated that pre-LD ALC may serve as a helpful indicator to predict the outcomes of CAR-T cell therapy in patients with R/R DLBCL.
Access the full article to read more here.
Read more here: Source link